These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24441047)

  • 1. Inflammation in coronary artery disease.
    Christodoulidis G; Vittorio TJ; Fudim M; Lerakis S; Kosmas CE
    Cardiol Rev; 2014; 22(6):279-88. PubMed ID: 24441047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective.
    Wilson PW
    Am J Med; 2008 Oct; 121(10 Suppl 1):S15-20. PubMed ID: 18926165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay.
    Martins TB; Anderson JL; Muhlestein JB; Horne BD; Carlquist JF; Roberts WL; Carlquist JF
    Am J Clin Pathol; 2006 Jun; 125(6):906-13. PubMed ID: 16690490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-alpha/IL-10 ratio and C-reactive protein as markers of the inflammatory response in CAD-prone North Indian patients with acute myocardial infarction.
    Goswami B; Rajappa M; Mallika V; Shukla DK; Kumar S
    Clin Chim Acta; 2009 Oct; 408(1-2):14-8. PubMed ID: 19576194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dietary therapy for prevention and treatment of atherosclerosis from the perspective of anti-inflammation].
    Tada N
    Nihon Rinsho; 2011 Jan; 69(1):110-8. PubMed ID: 21226270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical appraisal of inflammatory markers in cardiovascular risk stratification.
    Krintus M; Kozinski M; Kubica J; Sypniewska G
    Crit Rev Clin Lab Sci; 2014 Oct; 51(5):263-79. PubMed ID: 24918900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inflammatory concepts of atherosclerosis--clinical utility of C-reactive protein measurement].
    Gibas M; Miszczak-Smiałek J
    Wiad Lek; 2006; 59(3-4):242-5. PubMed ID: 16813272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease.
    Hung MJ; Cherng WJ; Cheng CW; Li LF
    Am J Cardiol; 2006 May; 97(10):1429-34. PubMed ID: 16679078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory biomarkers in coronary artery disease.
    Zakynthinos E; Pappa N
    J Cardiol; 2009 Jun; 53(3):317-33. PubMed ID: 19477372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma circulatory markers in male and female patients with coronary artery disease.
    Jha HC; Divya A; Prasad J; Mittal A
    Heart Lung; 2010; 39(4):296-303. PubMed ID: 20561855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of inflammation and coronary artery disease.
    Saadeddin SM; Habbab MA; Ferns GA
    Med Sci Monit; 2002 Jan; 8(1):RA5-12. PubMed ID: 11782689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.
    Li JJ; Fang CH
    Med Hypotheses; 2004; 62(4):499-506. PubMed ID: 15050096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced serum levels of vasostatin-2, an anti-inflammatory peptide derived from chromogranin A, are associated with the presence and severity of coronary artery disease.
    Lu L; Wang YN; Li MC; Wang HB; Pu LJ; Niu WQ; Meng H; Yang EL; Zhang RY; Zhang Q; Zhao Q; Chen QJ; De Caterina R; Shen WF
    Eur Heart J; 2012 Sep; 33(18):2297-306. PubMed ID: 22645192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory markers for risk stratification in primary prevention of cardiovascular disease: time for a 'multimarker' approach?
    Ikonomidis I; Lekakis J; Kremastinos DT
    Thromb Haemost; 2006 Mar; 95(3):397-8. PubMed ID: 16525564
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of inflammation in the pathogenesis of atherosclerosis].
    Banach M; Markuszewski L; Zasłonka J; Grzegorczyk J; Okoński P; Jegier B
    Przegl Epidemiol; 2004; 58(4):663-70. PubMed ID: 15810508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory markers in coronary artery disease.
    Ikonomidis I; Michalakeas CA; Parissis J; Paraskevaidis I; Ntai K; Papadakis I; Anastasiou-Nana M; Lekakis J
    Biofactors; 2012; 38(5):320-8. PubMed ID: 22628054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of coronary plaque formation and disruption].
    Matsuo Y; Akasaka T
    Nihon Rinsho; 2006 Apr; 64(4):633-41. PubMed ID: 16613179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil cationic protein: A new biomarker of coronary atherosclerosis.
    Niccoli G; Ferrante G; Cosentino N; Conte M; Belloni F; Marino M; Bacà M; Montone RA; Sabato V; Schiavino D; Patriarca G; Crea F
    Atherosclerosis; 2010 Aug; 211(2):606-11. PubMed ID: 20307883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation, C-reactive protein, and atherothrombosis.
    Ridker PM; Silvertown JD
    J Periodontol; 2008 Aug; 79(8 Suppl):1544-51. PubMed ID: 18673009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.